Seres’ SER-155 gains breakthrough status for BSIs reduction
A live biotherapeutic, SER-155 secured fast track status from the FDA in December 2023.
Services
CPI’s Medicines Manufacturing Innovation Centre takes delivery of PACE Just in Time (JIT) Clinical Trials Drug Dispensing System
Does Southeast Asia have a growing role in vaccine development?
AlloVir and Kalaris enter merger to advance retinal disease therapies
Invenra’s antibody gains US FDA designations for neuroblastoma treatment
Dr Reddy’s, Aurigene and Kainomyx to co-develop anti-malarials
Daiichi Sankyo-AstraZeneca’s ENHERTU gains BTD for breast cancer
Formosa and Apotex agree licence for post-ocular surgery relief
